Consequently, in the immediate post-transplant setting, insulin therapy or prescription of a medication for diabetes is generally required to manage postoperative hyperglycemia, especially given the requirement for high-dose immunosuppressants in this setting (2). This evidence concerns the gene INS and Hyperglycemia.